% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-09}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 48.

\begin{enumerate}[leftmargin=*]
\item Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z (2025). \textit{Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06913-9}{doi:10.1007/s00213-025-06913-9}.
\item Kangaslampi S, Lietz M (2025). \textit{Psychedelics and autobiographical memory - six open questions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06771-5}{doi:10.1007/s00213-025-06771-5}.
\item Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y (2025). \textit{Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06772-4}{doi:10.1007/s00213-025-06772-4}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland, John S. Partilla, Michael H. Baumann, Grant C. Glatfelter (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Mona Irrmischer, Drew Puxty, Barış Onur Yıldırım, J.B. Deijen, Hessel Engelbregt (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2024). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka (2024). \textit{Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Kimberly Sakai, Ellen Bradley, Joseph A. Zamaria, Gabrielle Agin-Liebes, D. Parker Kelley, Alexander Fish, Valeria Martini, Michelle C. Ferris, Emma Morton, Erin E. Michalak, Aoife O’Donovan, Joshua Woolley (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Arya Rahbarnia, Zhaoxia Li, Paul Fletcher (2023). \textit{Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Federica Benvenuti, Daniele Colombo, Laura Soverchia, Nazzareno Cannella, Esi Domi, Roberto Ciccocioppo (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy, Kyle Ambert, M Hausman, Viviana Trezza (2022). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Hartogsohn I, Petranker R (2022). \textit{Set and setting in microdosing: an oft-overlooked principle.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06249-8}{doi:10.1007/s00213-022-06249-8}.
\item Butler M, Jelen L, Rucker J (2022). \textit{Expectancy in placebo-controlled trials of psychedelics: if so, so what?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06221-6}{doi:10.1007/s00213-022-06221-6}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06170-0}{doi:10.1007/s00213-022-06170-0}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S. (2022). \textit{Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06066-z}{doi:10.1007/s00213-022-06066-z}.
\item Hase A, Erdmann M, Limbach V, Hasler G. (2022). \textit{Analysis of recreational psychedelic substance use experiences classified by substance.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06062-3}{doi:10.1007/s00213-022-06062-3}.
\item van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J. (2021). \textit{Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-05857-0}{doi:10.1007/s00213-021-05857-0}.
\item Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths (2020). \textit{Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-020-05533-9}{doi:10.1007/s00213-020-05533-9}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2019). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott (2019). \textit{Replication and extension of a model predicting response to psilocybin}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-019-05279-z}{doi:10.1007/s00213-019-05279-z}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T. (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. (2017). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. (2017). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. (2017). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Liechti ME, Dolder PC, Schmid Y. (2016). \textit{Alterations of consciousness and mystical-type experiences after acute LSD in humans.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-016-4453-0}{doi:10.1007/s00213-016-4453-0}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX. (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. (2012). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. (2011). \textit{Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-011-2358-5}{doi:10.1007/s00213-011-2358-5}.
\item Heekeren K, Daumann J, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E. (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Griffiths RR, Richards WA, McCann U, Jesse R. (2006). \textit{Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-006-0457-5}{doi:10.1007/s00213-006-0457-5}.
\item Herbert D. Kleber (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0461-9}{doi:10.1007/s00213-006-0461-9}.
\item Charles R. Schuster (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0460-x}{doi:10.1007/s00213-006-0460-x}.
\item David E. Nichols (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0458-4}{doi:10.1007/s00213-006-0458-4}.
\item Solomon H. Snyder (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0459-3}{doi:10.1007/s00213-006-0459-3}.
\item Francesca Bermond, Julien Bert (1968). \textit{Action de la psilocybine sur le comportement d'un cercopithecinae papio-papio}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00407043}{doi:10.1007/bf00407043}.
\end{enumerate}
\end{document}
